missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Alivin 1 Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA5113062
This item is not returnable.
View return policy
Description
Alivin 1 Polyclonal Antibody for Western Blot, ICC/IF, IHC (P), ELISA
A novel primary response gene, Alivin 1 (ali1), is an activity-dependent gene and promotes survival of neurons. Sequence analyses reveal that rat, mouse, and human Ali1 proteins contain seven leucine-rich repeats, one IgC2-like loop and a transmembrane domain, and display homology to Kek and Trk families. Results suggest that expression of ali1 promotes depolarization-dependent survival of the granule neuron. Mouse ali1 was mapped to a locus approximately 55.3 cM from the centromere on chromosome 15 that is syntenic to positional candidate loci for familial Alzheimer's disease type 5 and Parkinson's disease 8 on human chromosome 12.
Specifications
| Alivin 1 | |
| Polyclonal | |
| Unconjugated | |
| Amigo2 | |
| adhesion molecule with Ig like domain 2; adhesion molecule with Ig-like domain 2; AI415330; Ali1; alivin 1; alivin-1; amigo2; AMIGO-2; amigo2 {ECO:0000312; amphoterin induced gene 2; amphoterin induced gene and ORF 2; amphoterin-induced protein 2; AW208913; DEGA; differentially expressed in gastric adenocarcinoma; differentially expressed in gastric adenocarcinomas; EMBL:AAO48951.1}; transmembrane protein AMIGO2 | |
| Rabbit | |
| Protein G | |
| RUO | |
| 300186, 347902 | |
| -20°C or -80°C if preferred | |
| Liquid |
| ELISA, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.03% ProClin 300; pH 7.4 | |
| Q7TNJ4, Q86SJ2 | |
| Amigo2 | |
| Recombinant Human Amphoterin-induced protein 2 protein (420-522AA). | |
| 100 μg | |
| Primary | |
| Human, Rat | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction